Alzheimer's brains show inter-related changes in RNA and lipid metabolism

[1]  Yonggui Fu,et al.  The role of alternative polyadenylation in the antiviral innate immune response , 2017, Nature Communications.

[2]  T. Yamane,et al.  Phosphatidylcholine protects neurons from toxic effects of amyloid β-protein in culture , 2016, Brain Research.

[3]  Min Su Kang,et al.  Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease , 2016, Molecular Psychiatry.

[4]  H. Y. Lee,et al.  Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer's disease neuropathological deficits , 2016, Molecular Psychiatry.

[5]  W. M. van der Flier,et al.  Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment , 2016, Molecular Psychiatry.

[6]  Stuart J. Ritchie,et al.  Shared genetic aetiology between cognitive functions and physical and mental health in UK Biobank (N=112 151) and 24 GWAS consortia , 2015, Molecular Psychiatry.

[7]  A. Enejder,et al.  Plaque-associated lipids in Alzheimer’s diseased brain tissue visualized by nonlinear microscopy , 2015, Scientific Reports.

[8]  J. Kornhuber,et al.  Brain membrane lipids in major depression and anxiety disorders. , 2015, Biochimica et biophysica acta.

[9]  S. Quake,et al.  A survey of human brain transcriptome diversity at the single cell level , 2015, Proceedings of the National Academy of Sciences.

[10]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[11]  Gaston H. Gonnet,et al.  The OMA orthology database in 2015: function predictions, better plant support, synteny view and other improvements , 2014, Nucleic Acids Res..

[12]  Kathryn Roeder,et al.  Most genetic risk for autism resides with common variation , 2014, Nature Genetics.

[13]  H. Soreq,et al.  Global coevolution of human microRNAs and their target genes. , 2014, Molecular biology and evolution.

[14]  L. Wilkins.  Summary of evidence-based guideline update: Prevention of stroke in nonvalvular atrial fibrillation: Report of the Guideline Development Subcommittee of the American Academy of Neurology , 2014, Neurology.

[15]  Mikhail S. Gelfand,et al.  Neanderthal ancestry drives evolution of lipid catabolism in contemporary Europeans , 2014, Nature Communications.

[16]  Derick R. Peterson,et al.  Plasma phospholipids identify antecedent memory impairment in older adults , 2014, Nature Medicine.

[17]  C. Kase,et al.  Summary of evidence-based guideline update: Prevention of stroke in nonvalvular atrial fibrillation , 2014, Neurology.

[18]  H. Soininen,et al.  Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease , 2014, Neurobiology of Aging.

[19]  Erick R. Scott,et al.  Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease , 2013, Nature.

[20]  Carlos H. Andrade-Moraes,et al.  Cell number changes in Alzheimer's disease relate to dementia, not to plaques and tangles. , 2013, Brain : a journal of neurology.

[21]  Gabriel Gold,et al.  Alzheimer disease therapy—moving from amyloid-β to tau , 2013, Nature Reviews Neurology.

[22]  T. Südhof,et al.  Titration of Syntaxin1 in Mammalian Synapses Reveals Multiple Roles in Vesicle Docking, Priming, and Release Probability , 2013, The Journal of Neuroscience.

[23]  Xavier Llor,et al.  Identification of Novel Predictor Classifiers for Inflammatory Bowel Disease by Gene Expression Profiling , 2013, PloS one.

[24]  R. Bartha,et al.  Forebrain Deletion of the Vesicular Acetylcholine Transporter Results in Deficits in Executive Function, Metabolic, and RNA Splicing Abnormalities in the Prefrontal Cortex , 2013, The Journal of Neuroscience.

[25]  Aikaterini S. Papadopoulou,et al.  Alteration of the microRNA network during the progression of Alzheimer's disease , 2013, EMBO molecular medicine.

[26]  T. Balla,et al.  Phosphoinositides: tiny lipids with giant impact on cell regulation. , 2013, Physiological reviews.

[27]  R. Elkon,et al.  Alternative cleavage and polyadenylation: extent, regulation and function , 2013, Nature Reviews Genetics.

[28]  K. Zhao,et al.  RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway. , 2013, European review for medical and pharmacological sciences.

[29]  L. Tran,et al.  Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.

[30]  Markus Glatzel,et al.  CLP1 links tRNA metabolism to progressive motor-neuron loss , 2013, Nature.

[31]  Michael Benatar,et al.  Prion-like domain mutations in hnRNPs cause multisystem proteinopathy and ALS , 2013, Nature.

[32]  Y. Lee,et al.  Genome-wide pathway analysis of a genome-wide association study on multiple sclerosis , 2013, Molecular Biology Reports.

[33]  A. Verkhratsky,et al.  Astroglia in neurological diseases. , 2013, Future neurology.

[34]  U. Heinemann,et al.  Blood‐brain barrier dysfunction, TGFβ signaling, and astrocyte dysfunction in epilepsy , 2012, Glia.

[35]  J. Schneider,et al.  Overview and findings from the religious orders study. , 2012, Current Alzheimer research.

[36]  Pierre J. Magistretti,et al.  Oligodendroglia metabolically support axons and contribute to neurodegeneration , 2012, Nature.

[37]  Hermona Soreq,et al.  Cholinergic-associated loss of hnRNP-A/B in Alzheimer's disease impairs cortical splicing and cognitive function in mice , 2012, EMBO molecular medicine.

[38]  Berislav V. Zlokovic,et al.  Apolipoprotein E controls cerebrovascular integrity via cyclophilin A , 2012, Nature.

[39]  Hermona Soreq,et al.  Threshold-independent meta-analysis of Alzheimer's disease transcriptomes shows progressive changes in hippocampal functions, epigenetics and microRNA regulation. , 2012, Current Alzheimer research.

[40]  Marisa O. Hollinshead,et al.  Identification of common variants associated with human hippocampal and intracranial volumes , 2012, Nature Genetics.

[41]  H. Hakonarson,et al.  Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. , 2012, Human molecular genetics.

[42]  S. Leurgans,et al.  Cerebrovascular Disease Pathology and Parkinsonian Signs in Old Age , 2011, Stroke.

[43]  Yan Li,et al.  Ultra Performance Liquid Chromatography and High Resolution Mass Spectrometry for the Analysis of Plant Lipids , 2011, Front. Plant Sci..

[44]  Lothar Willmitzer,et al.  Elemental formula annotation of polar and lipophilic metabolites using (13) C, (15) N and (34) S isotope labelling, in combination with high-resolution mass spectrometry. , 2011, The Plant journal : for cell and molecular biology.

[45]  K. Nishida,et al.  Mechanisms and consequences of alternative polyadenylation. , 2011, Molecules and Cells.

[46]  N. Proudfoot.  Ending the message: poly(A) signals then and now. , 2011, Genes & development.

[47]  G. D. Paolo,et al.  Linking lipids to Alzheimer's disease: cholesterol and beyond , 2011, Nature Reviews Cancer.

[48]  L. Moran,et al.  Up-regulation of metallothionein gene expression in Parkinsonian astrocytes , 2011, neurogenetics.

[49]  S. Cichon,et al.  Association study of the GRIA1 and CLINT1 (Epsin 4) genes in a German schizophrenia sample. , 2011, Psychiatric genetics.

[50]  S. Pääbo,et al.  Rapid metabolic evolution in human prefrontal cortex , 2011, Proceedings of the National Academy of Sciences.

[51]  Vahram Haroutunian,et al.  Transcriptional vulnerability of brain regions in Alzheimer's disease and dementia , 2010, Alzheimer's & Dementia.

[52]  Michael Weiner,et al.  Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease , 2010, NeuroImage.

[53]  Nectarios Koziris,et al.  Accurate microRNA target prediction correlates with protein repression levels , 2009, BMC Bioinformatics.

[54]  J. Troncoso,et al.  ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain , 2009, Neurobiology of Aging.

[55]  B. Tian,et al.  Phylogenetic analysis of mRNA polyadenylation sites reveals a role of transposable elements in evolution of the 3′-end of genes , 2008, Nucleic acids research.

[56]  N. Woo,et al.  Distinct Role of Long 3′ UTR BDNF mRNA in Spine Morphology and Synaptic Plasticity in Hippocampal Neurons , 2008, Cell.

[57]  Lili Wan,et al.  SMN Deficiency Causes Tissue-Specific Perturbations in the Repertoire of snRNAs and Widespread Defects in Splicing , 2008, Cell.

[58]  B. McConkey,et al.  TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis , 2008, Nature Genetics.

[59]  Ashley I Bush,et al.  Metals in Alzheimer's and Parkinson's diseases. , 2008, Current opinion in chemical biology.

[60]  Y. Xing,et al.  A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function , 2008, The Journal of Neuroscience.

[61]  R. D'Hooge,et al.  Lipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice , 2007, The EMBO Journal.

[62]  L. Lim,et al.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.

[63]  R. Wurtman,et al.  The 3‐hydroxy‐3‐methylglutaryl co‐enzyme A reductase inhibitor pravastatin enhances neurite outgrowth in hippocampal neurons , 2006, Journal of neurochemistry.

[64]  Bin Tian,et al.  A large-scale analysis of mRNA polyadenylation of human and mouse genes , 2005, Nucleic acids research.

[65]  Jiang-Ning Zhou,et al.  The expression of calcium/calmodulin-dependent protein kinase II-α in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology , 2005, Brain Research.

[66]  Michael Recce,et al.  PolyA_DB: a database for mammalian mRNA polyadenylation , 2004, Nucleic Acids Res..

[67]  M. Mesulam,et al.  Cholinergic nucleus basalis tauopathy emerges early in the aging‐MCI‐AD continuum , 2004, Annals of neurology.

[68]  W. Markesbery,et al.  Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[69]  C. Geula,et al.  Neurobiology of butyrylcholinesterase , 2003, Nature Reviews Neuroscience.

[70]  M. Noda,et al.  Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[71]  Jorge R. Oksenberg,et al.  The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease , 2001, Science.

[72]  H. Soreq,et al.  Acetylcholinesterase — new roles for an old actor , 2001, Nature Reviews Neuroscience.

[73]  G. Huez,et al.  A GG Nucleotide Sequence of the 3′ Untranslated Region of Amyloid Precursor Protein mRNA Plays a Key Role in the Regulation of Translation and the Binding of Proteins , 2000, Molecular and Cellular Biology.

[74]  D. Gautheret,et al.  Patterns of variant polyadenylation signal usage in human genes. , 2000, Genome research.

[75]  J. Vandekerckhove,et al.  Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease. , 2000, Journal of lipid research.

[76]  S. Baek,et al.  Genomic structure and polymorphism of the human thromboxane synthase-encoding gene. , 1996, Gene.

[77]  H. Braak,et al.  Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.

[78]  M. Saarma,et al.  Multiple promoters direct tissue-specific expression of the rat BDNF gene , 1993, Neuron.

[79]  M. Kennedy,et al.  Conserved and variable regions in the subunits of brain type II Ca2+/calmodulin-dependent protein kinase , 1988, Neuron.

[80]  Zheng Yan,et al.  Widespread splicing changes in human brain development and aging , 2013 .

[81]  E. Domenici,et al.  Biomarkers for antipsychotic therapies. , 2012, Handbook of experimental pharmacology.

[82]  David Touboul,et al.  Time-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging reveals cholesterol overload in the cerebral cortex of Alzheimer disease patients , 2012, Acta Neuropathologica.

[83]  M. Palczewska,et al.  S100A proteins in propagation of a calcium signal in norm and pathology. , 2012, Postepy biochemii.

[84]  S. Teichmann,et al.  RNA sequencing reveals two major classes of gene expression levels in metazoan cells , 2011, Molecular systems biology.

[85]  J. Thome,et al.  A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoforms , 2007, Molecular Psychiatry.